Hair Contamination Leads to Hospira Aminosyn Recall

A recall has been issued for one lot of amino acid injection fluid manufactured by Hospira, after a consumer complaint was received involving at least one vial that was contaminated with hair.  

The Aminosyn II recall was announced by the FDA on August 30, after a consumer found foreign matter in the solution, which Hospira later confirmed to be a human hair follicle.

The affected lot of Aminosyn is an amino acid injection used at the user level to inject nitrogen and other vitamins for nutritional support for patients who are not capable of receiving oral nutrition is pill form.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Although no injuries have been reported in connection with the use of the amino acid injection fluid, injection of contaminated medications may cause a wide variety of problems depending upon a patient’s condition. According to the recall notice, patients typically may experience inflammation, phlebitis, and or low levels of allergic response but patients with more severe conditions with preexisting trauma may experience occluded capillaries and other high level risks.

The recall includes Aminosyn II 10%, Sulfite-Free, 500mL flexible containers with NDC number 0409-4164-03, Lot number 26-138-JT and has an expiration date of August 1, 2014. The affected lot was manufactured by Hospira Inc. and distributed nationwide to wholesalers, distributors, hospitals, and pharmacies between March 2013 and August 2013.

Hospira has been associated with multiple recalls over the past few years due to particulate matter contamination. Earlier this year, Hospira Inc. recalled one lot of .09% sodium chloride injection following a consumer complaint indicating particulates within the fluid which after further investigation were identified in four tested samples.

Additionally, Hospira recalled 15 lots of Pipercillin and Tazobactam injection fluids as well as their GemStar Infusion System simultaneously due to particulate matter contamination and voltage defects in the infusion system.

Those with existing product should verify the solution is part of the recalled lot and stop using/distributing the product immediately and quarantine it until they have called Stericycle at 1-866-737-4701 to arrange a return and replacement of the injection fluid.

Image Credit: |

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks
Johnson & Johnson Faces Medical Monitoring Lawsuit Over Future Baby Powder Cancer Risks (Posted today)

Women who used Johnson's Baby Powder around their genitals for feminine hygiene purposes now live in fear of developing ovarian cancer, according to the class action lawsuit seeking medical monitoring for future diagnoses

More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing
More Than 9,600 Join Suboxone Lawsuit Over Tooth Decay in MDL Filing (Posted yesterday)

A bundled complaint of about 9,600 Suboxone lawsuits were filed in federal court on Friday, ahead of the two-year anniversary of the FDA requiring tooth decay label warnings on the opioid treatment film strips, which is also a deadline for filing a civil complaint in many states.